# clm_0F6159727C59

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_research_and_development  
value: 143,149,000 United States dollar  
valid_from: 2011-06-30  
valid_to: 2011-09-30  
published: 2011-07-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_D248A8950FA4  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly research and development: 143,149,000 United States dollar", as of 2011-06-30 (until 2011-09-30). Claim clm_0F6159727C59, https://asof.is/claim/clm_0F6159727C59, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2011, filed 2011-07-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm (primary, SEC EDGAR 10-Q Q2 FY2011, published 2011-07-28)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 129,392,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_0F6159727C59](/claim/clm_0F6159727C59.md) | [clm_371C6065B00F](/claim/clm_371C6065B00F.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.